anecortave acetate has been researched along with alprostadil in 1 studies
| Studies (anecortave acetate) | Trials (anecortave acetate) | Recent Studies (post-2010) (anecortave acetate) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
|---|---|---|---|---|---|
| 68 | 9 | 6 | 7,136 | 864 | 761 |
| Protein | Taxonomy | anecortave acetate (IC50) | alprostadil (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustin, AJ; Offermann, I | 1 |
1 review(s) available for anecortave acetate and alprostadil
| Article | Year |
|---|---|
[Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches].
Topics: Alprostadil; Angiogenesis Inhibitors; Antioxidants; Choroidal Neovascularization; Clinical Trials as Topic; Combined Modality Therapy; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Triamcinolone; Vascular Endothelial Growth Factor A | 2008 |